140 related articles for article (PubMed ID: 6370719)
1. [Dipeptidyl carboxypeptidase inhibitors--a new class of antihypertensive agents].
Shvarts GIa
Farmakol Toksikol; 1984; 47(2):105-15. PubMed ID: 6370719
[No Abstract] [Full Text] [Related]
2. Novel drugs targeting hypertension: renin inhibitors and beyond.
Leibovitz E; Schiffrin EL
J Cardiovasc Pharmacol; 2007 Jul; 50(1):3-8. PubMed ID: 17666909
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
Abrahám G; Légrády P
Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.
Miatello RM
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):521-3. PubMed ID: 16309575
[No Abstract] [Full Text] [Related]
5. Inhibition of renin: an updated review of the development of renin inhibitors.
Li YC
Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
7. [To what extent can prostaglandin synthesis inhibitors of the non-steroidal antirheumatic (NSAR) type modify the effect of ACE inhibitors?].
Grote L
Internist (Berl); 1995 Dec; 36(12):1203-4. PubMed ID: 8567229
[No Abstract] [Full Text] [Related]
8. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
Soldner A; Spahn-Langguth H; Mutschler E
Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
[TBL] [Abstract][Full Text] [Related]
9. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
Minami J; Ishimitsu T; Matsuoka H
Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
[No Abstract] [Full Text] [Related]
10. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
11. [Hypertensive activity of isoteolin].
Zheliazkov D; Markov M
Eksp Med Morfol; 1984; 23(3):127-33. PubMed ID: 6549162
[No Abstract] [Full Text] [Related]
12. [Hypotensive effect of oxatriazolium-5-olate derivative].
Artem'eva MM; Postnikov AB; Akinfrieva OV; Daliger IL; Shevelev SA; Medvedev OS; Medvedeva NA
Eksp Klin Farmakol; 2008; 71(5):25-7. PubMed ID: 19093367
[TBL] [Abstract][Full Text] [Related]
13. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
Boucek P
Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
16. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis.
Yamaguchi N; Kawaguchi K; Yamamoto N
Eur J Pharmacol; 2009 Oct; 620(1-3):71-7. PubMed ID: 19686729
[TBL] [Abstract][Full Text] [Related]
17. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study of the antihypertensive activity of unithiol, D-penicillamine and cysteine].
Mashkovskiĭ MD; Shvarts GIa
Farmakol Toksikol; 1983; 46(6):24-8. PubMed ID: 6653753
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Weir MR
Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
